340 related articles for article (PubMed ID: 18387797)
1. Effect of disease duration on dose-response of inhaled budesonide in asthma.
Selroos O
Respir Med; 2008 Jul; 102(7):1065-72. PubMed ID: 18387797
[TBL] [Abstract][Full Text] [Related]
2. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma.
Evans DJ; Taylor DA; Zetterstrom O; Chung KF; O'Connor BJ; Barnes PJ
N Engl J Med; 1997 Nov; 337(20):1412-8. PubMed ID: 9358138
[TBL] [Abstract][Full Text] [Related]
3. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of budesonide Clickhaler and Turbuhaler in adult asthma.
Morice A; Das S; Ellis S;
J Asthma; 2005 Oct; 42(8):697-703. PubMed ID: 16266962
[TBL] [Abstract][Full Text] [Related]
5. Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma.
Banov CH; Howland WC; Lumry WR
Ann Allergy Asthma Immunol; 2001 Jun; 86(6):627-32. PubMed ID: 11428734
[TBL] [Abstract][Full Text] [Related]
6. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.
Kuna P; Creemers JP; Vondra V; Black PN; Lindqvist A; Nihlen U; Vogelmeier C
Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989
[TBL] [Abstract][Full Text] [Related]
7. Comparison of high and low dose of the inhaled steroid, budesonide, as an initial treatment in newly detected asthma.
Tukiainen H; Taivainen A; Majander R; Poussa T; Svahn T; Puolijoki H; Terho EO
Respir Med; 2000 Jul; 94(7):678-83. PubMed ID: 10926339
[TBL] [Abstract][Full Text] [Related]
8. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Taylor DR
Respir Med; 2000 Aug; 94(8):767-71. PubMed ID: 10955752
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of budesonide inhalation suspension: a nebulizable corticosteroid for persistent asthma in infants and young children.
White MV; Cruz-Rivera M; Walton-Bowen K
Fam Med; 1999 May; 31(5):337-45. PubMed ID: 10407712
[TBL] [Abstract][Full Text] [Related]
10. The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma.
Busse WW; Pedersen S; Pauwels RA; Tan WC; Chen YZ; Lamm CJ; O'Byrne PM;
J Allergy Clin Immunol; 2008 May; 121(5):1167-74. PubMed ID: 18405951
[TBL] [Abstract][Full Text] [Related]
11. Early intervention of recent onset mild persistent asthma in children aged under 11 yrs: the Steroid Treatment As Regular Therapy in early asthma (START) trial.
Chen YZ; Busse WW; Pedersen S; Tan W; Lamm CJ; O'Byrne PM
Pediatr Allergy Immunol; 2006 May; 17 Suppl 17():7-13. PubMed ID: 16573703
[TBL] [Abstract][Full Text] [Related]
12. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma.
Busse WW; Chervinsky P; Condemi J; Lumry WR; Petty TL; Rennard S; Townley RG
J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):457-63. PubMed ID: 9564797
[TBL] [Abstract][Full Text] [Related]
13. Dose-response comparison of budesonide dry powder inhalers using adenosine monophosphate bronchial challenge.
Lipworth BJ; Sims EJ; Das SK; Buck H; Paterson M
Ann Allergy Asthma Immunol; 2005 Jun; 94(6):675-81. PubMed ID: 15984601
[TBL] [Abstract][Full Text] [Related]
14. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma.
Haahtela T; Järvinen M; Kava T; Kiviranta K; Koskinen S; Lehtonen K; Nikander K; Persson T; Selroos O; Sovijärvi A
N Engl J Med; 1994 Sep; 331(11):700-5. PubMed ID: 8058076
[TBL] [Abstract][Full Text] [Related]
15. Thirteen-year follow-up of early intervention with an inhaled corticosteroid in patients with asthma.
Haahtela T; Tamminen K; Kava T; Malmberg LP; Rytilä P; Nikander K; Persson T; Selroos O
J Allergy Clin Immunol; 2009 Dec; 124(6):1180-5. PubMed ID: 20004779
[TBL] [Abstract][Full Text] [Related]
16. A single blinded randomised trial to compare the efficacy and safety of once daily budesonide (400microg) administered by turbuhaler with beclomethasone dipropionate (400microg) given twice daily through a metered-dose inhaler in patients with mild to moderate asthma.
Ige OM; Sogaolu OM
Afr J Med Med Sci; 2004 Jun; 33(2):155-60. PubMed ID: 15565935
[TBL] [Abstract][Full Text] [Related]
17. Benefits of low-dose inhaled fluticasone on airway response and inflammation in mild asthma.
Boulet LP; Turcotte H; Prince P; Lemière C; Olivenstein R; Laprise C; Larivée P; Bégin P; Laviolette M
Respir Med; 2009 Oct; 103(10):1554-63. PubMed ID: 19692221
[TBL] [Abstract][Full Text] [Related]
18. Potency ratio fluticasone propionate (Flixotide Diskus)/budesonide (Pulmicort Turbuhaler).
Ställberg B; Pilman E; Skoogh BE; Hermansson BA
Respir Med; 2007 Mar; 101(3):610-5. PubMed ID: 16889952
[TBL] [Abstract][Full Text] [Related]
19. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.
den Otter JJ; van Schayck CP; Folgering HT; van den Boom G; Akkermans RP; van Weel C
Eur J Gen Pract; 2007; 13(2):89-91. PubMed ID: 17534745
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, randomised, controlled trial assessing controller medications in asthma.
Shah AR; Sharples LD; Solanki RN; Shah KV
Respiration; 2006; 73(4):449-56. PubMed ID: 16407639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]